Fortimedix has been acquired by Medtronic

Fortimedix Surgical has been successfully acquired by Medtronic (NYSE: MDT). Following the transaction, Fortimedix will operate as Medtronic Articulating Technologies.

Located at the Brightlands Chemelot Campus in Geleen, the Netherlands, Fortimedix operates a fully equipped R&D and pilot manufacturing facility that allows the seamless integration of product development and pilot manufacturing under a single roof.

Oaklins’ team in the Netherlands acted as the exclusive sell-side M&A advisor to Fortimedix in its sale to Medtronic. This transaction underscores Oaklins’ strong international track record in the medical technology sector, demonstrating their ability to unlock significant value in a rapidly evolving, innovation-driven industry. Leveraging deep sector expertise and a global network of strategic buyers, the team ensured a smooth and successful transaction process for all parties involved.

Service

M&A sell-side

Parties

“Our goal was to find a strategic partner for Fortimedix capable of bringing our innovative technologies into full-scale production and into operating rooms worldwide. With Medtronic, we have now found the right partner who can take the next step in delivering groundbreaking instruments to the clinic. The intensive and very pleasant collaboration with Oaklins ultimately led to this transaction. The team’s guidance and results-oriented approach proved invaluable throughout the entire process.”

Wout Bijker

CEO, Fortimedix Surgical

Talk to the deal team

Robert Boersma

Partner

Amsterdam, Netherlands
Oaklins Netherlands

View profile Get in touch

Robbert Bon

Senior Associate

Amsterdam, Netherlands
Oaklins Netherlands

View profile Get in touch

Oscar van Rijn

Associate

Amsterdam, Netherlands
Oaklins Netherlands

View profile Get in touch

Related deals

MEDIK Hospital Design Group has been acquired by STERIS

Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Healthcare

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Learn more

SLT has been acquired by Indutrade

Healthcare

SLT has been acquired by Indutrade

SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.

Learn more